J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
malaymail on MSN1d
GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in MalaysiaGlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...
EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...
This came after GlaxoSmithKline Pharmaceuticals presented protocol amendment 03 dated 25 June 2024 protocol no. 209628.
The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Several important questions in the field of malaria vaccine research will be answered in the next few years. Phase III results from a multicenter trial will have determined the RTS,S efficacy ...
Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...
Teva Pharmaceutical Industries Ltd. ADR-1.19% $20.05B ...
After hours: 2 October at 19:51 GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback